MediWound (MDWD) Phase 3 Pediatric Study (CIDS) of NexoBrid for Eschar Removal of Severe Thermal Burns Mets Primary Endpoints
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/26/2024
Go back to MediWound (MDWD) Phase 3 Pediatric Study (CIDS) of NexoBrid for Eschar Removal of Severe Thermal Burns Mets Primary Endpoints
July 20, 2021 7:10 AM EDT
MediWound (NASDAQ: MDWD) to Resume Trading at 7:30 a.m.
...
More